Breast cancer medication risk
New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.
Sep 29, 2020
0
3
New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.
Sep 29, 2020
0
3
A new phase II trial finds that a combination of radiation therapy and immunotherapy led to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). ...
Feb 27, 2020
0
2
(HealthDay)—Endoscopic approaches are feasible for the surgical resection of sinonasal cancer, according to a study published online Dec. 24 in Head & Neck.
Jan 2, 2020
0
2
(HealthDay)—For patients with early-stage breast cancer, 10-year outcomes are similar for treatment with partial breast irradiation (PBI) and whole breast irradiation (WBI), according to a study presented at the annual ...
Dec 12, 2019
0
1
Results from the NRG Oncology phase I clinical trial NRG-GOG 9929 show that using the immunotherapy drug ipilimumab after chemoradiotherapy (CRT) is tolerated in the curative treatment of women with lymph node-positive cervical ...
Dec 3, 2019
0
1
(HealthDay)—Patients with multiple myeloma (MM) may receive a survival benefit from being treated at high-volume facilities, according to a study published in the September issue of the Journal of the National Comprehensive ...
Oct 2, 2019
0
1
Patients with sepsis often require surgery or imaging procedures under general anesthesia, yet there is no standard regimen for anesthetizing septic patients. Of volatile (inhaled) anesthetics, sevoflurane and isoflurane ...
Sep 12, 2019
0
0
(HealthDay)—Maintaining full doses of chemotherapy, especially early in the treatment course, is important for survival of intermediate or high-risk breast cancer patients, according to a study published in the August issue ...
Sep 11, 2019
0
5
About one of every five breast cancers presents with high levels of HER2 proteins. Known as HER2-positive breast cancer, these tumors typically show an aggressive behavior—a greater likelihood of metastasis and relapse ...
Jun 25, 2019
0
0
A new study is the first to establish a nationwide treatment protocol that can save lives of patients with cardiogenic shock (CS), a deadly heart attack complication. Findings show 72 percent of patients with CS survived ...
May 21, 2019
0
0